Skip to main content
. 2013 Sep 30;45(3):210–219. doi: 10.4143/crt.2013.45.3.210

Fig. 1.

Fig. 1

Effect of interleukin 6 (IL-6) on breast cancer recurrence-free survival according to HER2 status: (A) HER2 positive and (B) HER2 negative.